Communiqués Olink Holding AB

Actions

OLK

US6807101000

Temps réel estimé Cboe BZX Autres places de cotation 21:44:04 07/06/2024			Varia. 5j.	Varia. 1 janv.
24,71 ^USD	+1,06 %		+2,92 %	-1,99 %

06/06	Le panel de surveillance immunitaire Olink® Target 48 ? la prochaine frontière dans le profilage des biomarqueurs immunitaires avec une confiance absolue	CI
30/05	Des chercheurs utilisent Olink® ? Explore pour identifier les protéines circulantes susceptibles d'avertir d'un cancer 7 ans avant le diagnostic	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Olink Target 48 Immune Surveillance Panel, the Next Frontier in Immune Biomarker Profiling with Absolute Confidence	14:42	AQ
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence	06/06	GL
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05	GL
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	30/05	AQ
Olink reports first quarter 2024 financial results	13/05	GL
Sampled Named One of the First Olink Certified Service Providers	06/05	AQ
Olink : Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability - Form 6-K	19/04	PU
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024	19/04	GL
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease	02/04	GL
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease	02/04	AQ
Olink publishes 2023 annual report	25/03	GL
Olink publishes 2023 annual report	25/03	AQ
Olink reports fourth quarter and full year 2023 financial results	25/03	GL
Notice to attend the Annual General Meeting of Olink Holding AB (publ)	15/03	GL
Olink announces change of date for Annual General Meeting	08/03	GL
Olink announces change of date for Annual General Meeting	08/03	AQ
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink	04/03	AQ
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools	20/12	AQ
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink	18/12	AQ
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink	04/12	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Olink Holding AB

Actions

OLK

US6807101000

Communiqués

Filtres